Milestones, recognition and stories from Foshan Chancheng Hospital.
From the International Healthcare Zone in Phase 1 to the Intelligent Healthcare Exhibition Area in Phase 3, Fosun Health presented China’s cross-border medical capabilities to global visitors.
Read more →
At Foshan Chancheng Hospital’s International Medical Center, 64-year-old Ani found a robot-assisted solution to complex spinal disease — and a warmth of care that crossed borders.
Read more →
Fosun Health opened the Smart Healthcare Exhibition Area at Phase 3 of the 140th Canton Fair with a robotics team, an AI-assisted patient pathway and a set of devices that follow patients home, alongside the international medical centers of its Greater Bay Area hospitals.
Read more →
A patient from Kazakhstan became the first in Foshan to receive intrathecal tofersen for SOD1-related ALS — the city's first therapy aimed at the cause of the disease rather than at its symptoms alone.
Read more →
In three days the delegation signed with hospitals in Hanoi, Gia Lai and Ho Chi Minh City, opened an international teleconsultation room and addressed Vietnamese oncologists on CAR-T.
Read more →
Yangcheng Evening News walked the Fair2Care zone and the Canton Fair Organizing Committee shared the report — on AI pulse diagnosis, TCM therapies and the logistics of reaching care from abroad.
Read more →
Calf pain raised at the exhibition stand was checked on site, then referred to hospital rather than massaged away — and about an hour later the visitor was in a consulting room at the International Medical Center.
Read more →
Fosun Health became the first cross-border international healthcare group to exhibit at the Canton Fair, bringing FIMC and three sister Greater Bay Area hospitals to the fair's first International Healthcare Zone, where international buyers queued for TCM therapies and health screening.
Read more →
After five years of seeking treatment across borders with little improvement, an 8-year-old boy from Bangladesh completed his treatment in Foshan — and his father wrote a heartfelt thank-you letter to Dr. Xin Jing and Dr. Liang Fujian.
Read more →
Five domestic manufacturers — led by full-magnetic-levitation designs with 670+ implants — have cut artificial-heart therapy from about ¥1.5 million for a single imported pump to roughly ¥360,000, opening bridge-to-transplant therapy to far more patients.
Read more →
The First Affiliated Hospital of Jinan University completed its tenth LVAD implantation for a critically ill truck driver with end-stage heart failure — as experts warn that chronic overwork is also a trigger of heart failure.
Read more →
Prof. Peng Yucheng and Prof. Han Wei's teams completed TEER with DragonFly — China's first China-EU dual-certified mitral clip system — implanting two clips in an 82-year-old patient, bringing severe regurgitation down to trace.
Read more →
Foshan Chancheng Hospital completed the first mainland-China clinical use of the Diamondback 360 coronary orbital atherectomy system — a dual-effect solution that ablates superficial calcium and loosens deep calcium for severely calcified lesions.
Read more →
A fully magnetically levitated homegrown LVAD weighing only 75 grams was implanted on a beating heart through bilateral mini-incisions — the device now runs steadily and the patient's recovery has exceeded expectations.
Read more →
Five-year follow-up of Axi-cel shows 42.6% overall survival in refractory patients, 65% complete response and 54.6% four-year survival in second-line disease, with consistent Chinese real-world evidence of 83% response.
Read more →
China's first approved CAR-T cell therapy marks five years: 1,500+ patients treated, its first patient cancer-free for over eight years, 200+ treatment centers in 29 provinces, and a third indication in breakthrough development.
Read more →
Foshan Chancheng Hospital completed the Greater Bay Area's first T-cell collection for sattikecel (CT041), the world's first approved CAR-T for solid tumors, for a gastric cancer patient previously treated in Mongolia and South Korea.
Read more →
The BCMA/CD19 dual-target autologous CAR-T received implicit clinical trial approval for relapsed/refractory primary light chain amyloidosis — a rare disease with scarce treatment options.
Read more →
The partnership will localize Fosun Kairos's CAR-T cell therapy in Saudi Arabia — covering local manufacturing, registration and commercialization under Vision 2030.
Read more →
The hospital presented its FIMC center, 60 Hong Kong-Macao device approvals, direct insurance billing and end-to-end international patient services at the Beijing forum.
Read more →
The Allurion swallowable gastric balloon, placed without endoscopy or anesthesia, was used for the first time in mainland China outside Hainan at Foshan Chancheng Hospital — a 15-minute outpatient procedure.
Read more →
A da Vinci robotic right lower lobectomy removes a suspicious lung nodule while preserving healthy tissue and minimizing trauma, supported by FIMC international services.
Read more →
A multidisciplinary team removed an invasive glomus jugulare tumor spanning the skull base, temporal bone and upper neck—without a blood transfusion.
Read more →
Foshan Chancheng Hospital gave the first local Iloprost injection under the Greater Bay Area policy, opening a new limb-salvage pathway for severe diabetic foot.
Read more →
An overseas patient who had sought care in Singapore came to Foshan Chancheng Hospital for a 10-day integrated TCM program; renal markers and symptoms improved.
Read more →
A 20-year-old woman with TSC-related kidney tumor traveled 2,800 km from Dhaka to Foshan for robot-assisted surgery that preserved her kidney.
Read more →
A delegation of 14 senior healthcare professionals from seven South Pacific island nations visited FIMC for clinical exchange and TCM experience.
Read more →
Foshan Chancheng Hospital successfully implanted a leadless "capsule" pacemaker — scar-free, minimally invasive, with a battery life of nearly 17 years.
Read more →
The hospital's TCM division was recommended among "2025 Guangdong's Strongest Departments", recognizing its clinical and research excellence.
Read more →
A Bangladeshi patient with IgA nephropathy and more than a dozen overlapping conditions had been treated without success in Saudi Arabia, India and Bangladesh before a multidisciplinary team in Foshan reached a diagnosis.
Read more →
Wheelchair-bound by knee pain, facial swelling and constant dryness, 21-year-old Salsabilla arrived in Foshan without a diagnosis. A multidisciplinary team found atypical lupus — and a hospital that made room for her faith.
Read more →
After a fall at home left him unable to sleep for the pain, Mr. Leung needed a hip replacement. His condition for choosing a hospital was not the surgery itself but the recovery — and he travelled from Hong Kong to Foshan to get it.
Read more →
A train-station fall left American teacher Arian with shoulder pain for two and a half years. He had already trusted Foshan Chancheng Hospital with his knee — this time he named the hospital before the doctors finished recommending surgery.
Read more →
Severe coronary calcification is the lesion interventional cardiologists dread most: balloons will not expand and devices will not pass. A dual-mechanism orbital atherectomy system, now in use at Foshan Chancheng Hospital through the HK-Macao Drug & Equipment Connect channel, sands superficial calcium and fractures deep calcium with a single 1.25 mm burr.
Read more →
Through health-management centers and regular free screenings, Chancheng extends preventive care beyond hospital walls across Foshan.
Learn more →